COPT Defense Properties (CDP) Projected to Post Earnings on Thursday

by · The Cerbat Gem

COPT Defense Properties (NYSE:CDPGet Free Report) will likely be issuing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.71 per share and revenue of $188.7920 million for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, February 6, 2026 at 12:00 PM ET.

COPT Defense Properties Trading Down 0.4%

NYSE:CDP opened at $30.68 on Tuesday. The company has a market capitalization of $3.47 billion, a PE ratio of 23.07 and a beta of 0.86. COPT Defense Properties has a 52-week low of $23.92 and a 52-week high of $31.24. The stock’s 50 day moving average price is $29.45 and its 200 day moving average price is $29.00. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 1.57.

COPT Defense Properties Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st were given a dividend of $0.305 per share. The ex-dividend date was Wednesday, December 31st. This represents a $1.22 dividend on an annualized basis and a dividend yield of 4.0%. COPT Defense Properties’s dividend payout ratio (DPR) is 91.73%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. CIBC Bancorp USA Inc. acquired a new stake in COPT Defense Properties in the third quarter valued at about $353,000. CANADA LIFE ASSURANCE Co lifted its holdings in shares of COPT Defense Properties by 5.0% in the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 262,044 shares of the company’s stock valued at $7,641,000 after buying an additional 12,517 shares during the period. Dark Forest Capital Management LP boosted its stake in shares of COPT Defense Properties by 7.1% in the third quarter. Dark Forest Capital Management LP now owns 211,410 shares of the company’s stock valued at $6,144,000 after buying an additional 14,091 shares in the last quarter. XTX Topco Ltd boosted its stake in shares of COPT Defense Properties by 28.8% in the third quarter. XTX Topco Ltd now owns 35,052 shares of the company’s stock valued at $1,019,000 after buying an additional 7,839 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV acquired a new position in COPT Defense Properties during the third quarter worth $212,000.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CDP shares. Wells Fargo & Company upped their price target on shares of COPT Defense Properties from $30.00 to $33.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Weiss Ratings restated a “buy (b-)” rating on shares of COPT Defense Properties in a research note on Wednesday, January 21st. New Street Research set a $33.00 target price on shares of COPT Defense Properties in a report on Monday, October 13th. Cantor Fitzgerald set a $33.00 price target on COPT Defense Properties in a report on Monday, January 5th. Finally, Evercore ISI dropped their price target on COPT Defense Properties from $35.00 to $34.00 and set an “outperform” rating on the stock in a research report on Monday, December 15th. Five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $33.00.

Read Our Latest Research Report on CDP

COPT Defense Properties Company Profile

(Get Free Report)

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.

Read More